|
End-of-day quote
LUXEMBOURG S.E.
28/09/2026
|
5-day change | 1st Jan Change | ||
| 38.20 USD | -2.05% |
|
-5.91% | +26.49% |
| 18/09 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 12/08 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,175.59 | +18.37% | 32 | |||||||
| 14,933.33 | +34.78% | 12 | |||||||
| 1,197.45 | -1.44% | 30 | |||||||
| 1,509.08 | +9.06% | 36 | |||||||
| 257.83 | -1.02% | 6 | |||||||
| - | 2,508.33 | +4.1% | 12 | ||||||
| 13,214.57 | +6.57% | 7 | |||||||
| 2,497.73 | +7.4% | 11 | |||||||
| - | - | - | - | - | |||||
| 3,796.46 | +7.69% | 13 | |||||||
| 172.67 | +8.44% | 3 | |||||||
| 15.11 | +57.03% | 4 | |||||||
| - | - | - | - | - | |||||
| - | - | 133.12 | +5.4% | 2 | |||||
| - | 153.75 | +18.18% | 5 | ||||||
| - | - | 14.6 | +9.36% | 1 | |||||
| - | 2,765 | -3.07% | 2 | ||||||
| Average | 3,022.98 | +12.06% | 12 | ||||||
| Weighted average by Cap. | 5,268.44 | +16.86% | 19 |
- Stock Market
- Stocks
- RICHTER Stock
- CHWGR Stock
- Sector Gedeon Richter
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















